Abstract:Type 2 diabetes is a progressive and complex condition that is difficult to cure in log run. α-Glucosidase inhbitors seems to be most effective in the treatment of diabtes. β-lactams reported for few antidiabetic property with α-glucosidase inhibitory activity. The current study aims at evaluating the potential of newly synthesized β-lactams B8-B14 as α-glucosidase inhibitors which can help in controlling the high blood glucose level in type 2 diabetes mellitus. Herein, the synthesized 3-nitrophenyl imine derivatives (1 eq.) reacted with ethenone (1 eq.) in benzene by staudinger cycloaddition reaction to afford the synthesis of β-lactams B8-B14 and confirmed by advanced spectroscopic techniques and elemental analysis. The antihyperglycemic studies revealed that compounds (B8, B9, B12-B14) at a dosage of 5 mg/kg and after 24 h of administration showed higher percentage of decrease in blood sugar (12.61-21.07%) than reference drug glibenclamide (11.74%). In line with in vitro studies, β-lactams B8 and B9 proved as potent inhibitors of α-glucosidase enzyme with IC50 values 3.33 μM and 2.21 μM respectively higher than standard drug acarbose (IC50= 5.47 μM). Further, in vivo experiment confirmed that the most potent antidiabetic agents B8 and B9 significantly decrease the ALT level (71.1-74.3%) to prevent the liver injury induced by diabetes. The higher antioxidant potential confirmed the role of B9 as lead antidiabetic agent to manage the ROS generated by diabetes. Autodock vina used to identify the catalytic sites of α-glucosidase and to remove water molecules and add hydrogen and kollman charges to protein structure. In molecular docking studies, B9 tightly fit within the catalytic pocket of the α-glucosidase enzyme with a binding affinity of -9.1 kcal/mol that supported its potential as a strong α-glucosidase inhibitor. The most potent compound B9 found to have optimal lipophilicity (2.63), highest druglikeness (86.9%) and excellent gastrointestinal absorption that are suitable for bioavailability and drug design. Moreover these physiochemical properties also showed excellent correlation of to the α-glucosidase inhibitory and antidiabetic activity. Overall, these excellent results suggest that the most potent compound B9 has the potential to develop as a therapeutic drug in the future to treat diabetes with α-glucosidase inhibitory activity.

Synthesis and Hypoglycemic Effect of N-[(3-(4-ethoxybenzyl)-4-chlorophenyl]-1-deoxynojirimycin

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Research Progress in Origin and Synthesis of 1-Deoxynojirimycin

Chemical synthesis, inhibitory activity and molecular mechanism of 1-deoxynojirimycin–chrysin as a potent α-glucosidase inhibitor

Synthesis and Biological Evaluation of Novel Benzyl-Substituted (S)-Phenylalanine Derivatives As Potent Dipeptidyl Peptidase 4 Inhibitors.

Synthesis,Characterization and Antidiabetic Activities of Novel Genipin Derivatives

Synthesis and Biological Activity of Novel Deoxynojirimycin Derivatives As Potent Alpha-Glucosidase Inhibitors

Effect of 1-Deoxynojirimycin Isolated from Mulberry Leaves on Glucose Metabolism and Gut Microbiota in a Streptozotocin-Induced Diabetic Mouse Model

Synthesis and Biological Evaluation of Pyrrolidine-2-carbonitrile and 4-Fluoropyrrolidine-2-carbonitrile Derivatives As Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes.

Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives]

Design, synthesis, biological evaluation, and docking study of chromone-based phenylhydrazone and benzoylhydrazone derivatives as antidiabetic agents targeting α‐glucosidase

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: a failure at shortening time on a crisis-intervention unit.

Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting α-amylase, and α-glucosidase: synthesis, molecular docking, and ADMET studies

Ultrasound-assisted synthesis of 4-thiazolidinone Schiff bases and their antioxidant, α-glucosidase, α-amylase inhibition, mode of inhibition and computational studies

Evaluation of the anti-hyperglycemic effect and safety of microorganism 1-deoxynojirimycin

[Synthesis, Biological Activity and Molecular Docking Research of N-{[(4-oxo-thiochroman-3-yl)phenyl]-methyl}acetamide Derivatives As Α-Glucosidase Inhibitors].

Synthesis and Biological Evaluation of β-lactams as Potent Antidiabetic Agents

A Novel Dipterocarpol Derivative that Targets Alpha‐Glucosidase and NLRP3 Inflammasome Activity for Treatment of Diabetes Mellitus

Synthesis, highly potent α-glucosidase inhibition, antioxidant and molecular docking of various novel dihydropyrimidine derivatives to treat diabetes mellitus

Integrative bioinformatic and experimental analysis of benzoylbenzodioxol derivatives: hypoglycemic potential in diabetic mice